Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2009
12/10/2009US20090304830 Composition Comprising Bamboo Extract for Androgen Agonist
12/10/2009US20090304815 Method of treatment for muscular dystrophy
12/10/2009US20090304748 Clostridial toxin pharmaceutical compositions
12/10/2009CA2726706A1 Water-soluble extracts of artemisia dracunculus (tarragon) for improvement of glucose metabolism
12/10/2009CA2726244A1 Dpp-iv inhibitors for use in the treatment of nafld
12/09/2009EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009EP2130443A1 Water-soluble extracts of Artemisia dracunculus (tarragon) for improvement of glucose metabolism
12/09/2009EP1458754B1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
12/09/2009CN101600423A Composition for amelioration/prevention of adverse side effect in steroid therapy
12/09/2009CN101597294A 3-aminoalkaneacylamino-rutaecarpine and 3-aminoalkaneacylamino-7,8-dehydrorutaecarpine derivative
12/09/2009CN101597272A Sodium salt compound of Iguratimod, preparation method thereof and pharmaceutical use thereof
12/09/2009CN101597271A Iguratimod derivatives, preparation method thereof and pharmaceutical use thereof
12/09/2009CN101596223A Method for enriching ginkgetin compound
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009US7628988 Induce cell differentiation; process control
12/08/2009CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/08/2009CA2375986C Substituted pyrazole compounds
12/03/2009WO2009146310A1 Deuterated tizanidine
12/03/2009WO2009146033A2 Compositions and methods for modulating smn activity
12/03/2009WO2009145590A2 Phenyl piperazine compounds, pharmaceutical composition comprising the same, and use thereof
12/03/2009WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009WO2009144278A2 USES OF CONGLUTIN-γ
12/03/2009WO2009144093A1 Hydroxytyrosol benefits mitochondria
12/03/2009US20090297640 Nutritional composition for increasing creatine uptake in skeletal muscle
12/03/2009US20090297538 Neurotoxic oligomers
12/03/2009CA2726231A1 Uses of conglutin-y
12/02/2009EP2128260A2 Modified TGF-beta superfamily proteins
12/02/2009EP2127647A1 Composition for inhibiting muscle damage
12/02/2009EP2124992A2 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
12/02/2009EP1523321B1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass
12/02/2009CN101590189A Traditional Chinese medicine composition containing radix aconiti carmichaeli for treating myasthenia gravis and preparation thereof
12/02/2009CN101590164A Traditional Chinese medicine composition containing radix astragalus for treating myasthenia gravis and preparation thereof
12/01/2009US7625943 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625919 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
11/2009
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009142195A1 Agent for induction/maintenance of remission
11/26/2009WO2009141159A1 2,5-disubstituted imidazo[4,5-c]pyridines for treating muscular dystrophy
11/26/2009WO2008150477A3 N-acetyl mannosamine as a therapeutic agent
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291953 Pharmaceutical salts of reboxetine
11/26/2009US20090291928 Composition for amelioration/prevention of adverse side effect in steroid therapy
11/26/2009CA2724592A1 Agent for maintenance of induced remission
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/26/2009CA2688469A1 2,5-disubstituted imidazo[4,5-c]pyridines for treating muscular dystrophy
11/25/2009EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009EP2123652A1 Heterocyclic compound
11/25/2009CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009CN101584869A Method of differentiating/inducing bone marrow interstitial cells into nerve cells and skeleton muscle cells by transferring notch gene
11/24/2009US7622612 Tricyclic derivatives and their use
11/24/2009CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009CA2338533C Method of treating an autoimmune disorder
11/19/2009WO2009140448A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009WO2009139876A2 Regenerating and enhancing development of muscle tissue
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009137880A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009WO2009137879A1 Orally administrable dosage forms comprising angiogenin and uses thereof
11/19/2009US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285791 Regenerating and enhancing development of muscle tissue
11/19/2009DE102008016275A1 Composition, useful e.g. transfection comprises a non-viral gene delivery system containing e.g. cationic lipid, and an agent for partial suppression and/or activation of innate intracellular and/or intercellular immune defense
11/19/2009CA2724629A1 Tetrahydrocyclopenta[b]indole androgen receptor modulators
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009CA2724048A1 Oral preparation
11/19/2009CA2723987A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/18/2009EP2119718A1 Macrocyclic compound
11/18/2009EP2119440A1 Amidino derivatives for use in the prevention or treatment of retinitis pigmentosa and Leber's disease
11/18/2009EP1397357B9 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/18/2009EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses
11/18/2009CN101583353A Composition for inhibiting muscle damage
11/17/2009US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
11/17/2009US7618634 Neurotoxic oligomers
11/17/2009US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders
11/17/2009CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
11/17/2009CA2402524C Methods of making and using 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxy-4-estren-3-one 17.beta.-trans-4-n-butylcyclohexane carboxylate and 7.alpha.,11.beta.-dimethyl-17.beta.-hydroxyestr-4-en-3-one 17-undecanoate
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/12/2009WO2009105691A3 Uses of pentamidine and related compounds
11/12/2009US20090281174 Senescence inhibitor
11/12/2009US20090281165 Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies
11/11/2009EP2114437A2 Modified corticotropin releasing factor peptides and uses thereof
11/11/2009EP2114411A2 Composition and method for protecting mitochondria
11/11/2009EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
11/11/2009EP1537104B1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009CN101575341A Amidocyanogen amido xanthone pyridine derivant, and preparation method and application thereof
11/11/2009CN101574490A Traditional Chinese medicine composition for curing lumbar muscle strain
11/11/2009CN101574489A Traditional Chinese medicine preparation for curing lumbar muscle strain
11/11/2009CN101574432A Traditional Chinese medicine preparation for curing lumbar muscle strain
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 233